Cargando…

928. Barriers to Hepatitis C Elimination in an Urban Clinic Offering Integrated HIV/HCV Treatment

BACKGROUND: Treatment of Hepatitis C virus (HCV) infection for persons with Human Immunodeficiency Virus (HIV) is dependent on consistent outpatient follow-up. We sought to identify factors that are associated with lower HCV treatment rates in HIV/HCV co-infected patients followed at Rutgers Infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correia, Lauren A, Tseng, Christopher C, Portilla, Mario, Swaminathan, Shobha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776616/ http://dx.doi.org/10.1093/ofid/ofaa439.1114

Ejemplares similares

Hepatitis C virus treatment response to ledipasvir/sofosbuvir among patients coinfected with HIV and HCV: Real world data in a black population
por: Banga, Jaspreet, et al.
Publicado: (2020)

Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir Among Patients Co-Infected with HIV and HCV: Real-world Data in a Black Population
por: Banga, Jaspreet, et al.
Publicado: (2017)

355. Barriers for Hepatitis C Elimination in HIV/HCV Coinfected Patients
por: Espinoza, Joe, et al.
Publicado: (2019)

P928: REAL-LIFE ANALYSIS OF THE MULTIPLE MYELOMA PATIENT’S SURVIVAL IN A LARGE COHORT OF PATIENTS
por: Lopez-Muñoz, N., et al.
Publicado: (2022)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

601. Disparities in Diabetes Care: Smoking Cessation among Women and Minorities Living with HIV at an Urban Academic Medical Center
por: Cangialosi, Peter, et al.
Publicado: (2020)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

928. Clinical Characteristics and Microbiology Testing Patterns Among Transplant Recipients Admitted to Acute Care Hospitals for Suspected Infection
por: Hill, T Matthew, et al.
Publicado: (2021)

615. Overlooking those at Intermediate Risk? ASCVD Prevention Measures among People Living with HIV at an Urban Academic Medical Center
por: Liotta, Mark, et al.
Publicado: (2020)

962. Linkage to Care Outcomes among Known HIV-Positive Patients at a High Prevalence Urban Hospital Emergency Department
por: Sudyn, Alexander W, et al.
Publicado: (2020)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

SUN-928 Adrenal Plasmacytoma in Multiple Myeloma Patient-An Unusual Presentation
por: Mathew, Jeena, et al.
Publicado: (2020)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

P928: OCULAR ADVERSE EVENTS AND FUNCTIONAL IMPACT IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL
por: Terpos, Evangelos, et al.
Publicado: (2023)

908. Dismantling Barriers to Hepatitis Elimination: Automated Hepatitis C Screening with Care and Cure by a Primary Care Based Team
por: Xu, Binghong, et al.
Publicado: (2021)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions
por: Sobrino-Vegas, Paz, et al.
Publicado: (2014)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
por: Meijide, Héctor, et al.
Publicado: (2010)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic
por: Hartl, Lukas, et al.
Publicado: (2022)

968. The Impact of Opt-Out HIV Screening and Patient Navigator-Assisted Linkage to Care of Newly Diagnosed Persons with HIV in a High-Prevalence Emergency Department
por: Kodali, Swetha, et al.
Publicado: (2020)

Development of a test system for simultaneous detection of HIV RNA and Hepatitis C virus (HCV) and DNA of Hepatitis B virus (HBV) in blood samples
por: Shahrokhi, Nader, et al.
Publicado: (2010)

Barriers to accessing health services during the COVID-19 pandemic in Poland: A nationwide cross-sectional survey among 109,928 adults in Poland
por: Mularczyk-Tomczewska, Paulina, et al.
Publicado: (2022)

Missed Testing Opportunities for HIV Screening and Early Diagnosis in an Urban Tertiary Care Center
por: DeRose, Joseph, et al.
Publicado: (2017)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

Hepatitis C diagnosics: clinical evaluation of the HCV-core antigen determination
por: van Helden, Josef
Publicado: (2014)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
por: Popping, Stephanie, et al.
Publicado: (2019)

932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned
por: Chew, Debra, et al.
Publicado: (2014)

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies
por: Krauth, Christian, et al.
Publicado: (2019)

Hepatitis C virus screening in Piemonte: an effective strategy to eliminate HCV chronic infections
por: Thomas, R, et al.
Publicado: (2023)

836. Significant Elevations in CD4(+) Count, Post-treatment of Chronic Hepatitis C (HCV) with Direct Acting Antivirals (DAAs), in Human Immune Deficiency, HIV/HCV Co-infected Patients with Prolonged CD4+ lymphocytopenia, despite undetectable HIV RNA
por: Kuhn, Ryan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qem81v99oc9dbt0ro4ksorns50